Myeloma Minute: BSRI Moves Closer to A Cure

myelomaMinBanner9.13.18.png

| INNOVATION | Latest Research

Thinking Outside The Box.png

Thinking Outside of the Box to Conquer Multiple Myeloma: the Black Swan Research Initiative Moves Ever Closer to a Cure

The IMF’s Black Swan Research Initiative® has changed the way we look at multiple myeloma. Six years ago, the original team, led by IMF Chairman Brian G.M. Durie, MD, concluded that the only way to cure the disease was to be able to identify it and treat it vigorously before it was too late. Fast-forward to 2019 the BSRI has made tremendous progress, with more than 50 sites around the world where investigators are implementing MRD testing into their clinical trials. “We can talk about the potential for curing myeloma, because we are so close, and we feel that we are, in fact, already most likely curing patients in the cure trials,” says Dr. Durie. “We have ideas and ways to expand the percentage of patients who are curable, which is just truly remarkable.”

Watch_Now_Button.png

| INNOVATION | Latest Research

Blog-BigBangImage.jpg

Will we unravel the “big bang” moment of myeloma in 2019?

One of the earliest indicators of disease progression is the subject of intense investigation by IMF Black Swan Research Initiative teams in Spain. This approach, says IMF Chairman Brian G.M. Durie, MD, “is like taking myeloma research back to the “big bang” moment.” Early disease, it turns out, is earlier than we may have thought.

ReadBlogButton.png

| EDUCATION | Workshop

250x250LaJolla.png

| INSPIRATION | Be a Warrior

Be a Warrior.png

Register Now for a Regional Community Workshop in La Jolla, California
Update Your Facebook Profile Picture with a #MyelomaWarrior Frame

The IMF will host a Regional Community Workshop at the San Diego Marriot (4240 La Jolla Village Dr.) in La Jolla, CA, on Saturday, March 23, 2019. Registration is FREE, but seating is limited. Here’s your chance to learn from and meet one-on-one with myeloma experts Caitlin Costello, MD (UCSD/Sharp Healthcare Transplant Program, San Diego, CA), David H. Vesole, MD, PhD (John Theurer Cancer Center, Hackensack, NJ), and Deborah Doss RN, OCN (Dana-Farber Cancer Institute, Boston, MA).

Amplify multiple myeloma awareness by updating your Facebook profile picture with an “I am a #MyelomaWarrior” frame. It’s easy. Click the link below to learn the 5 steps to adding a frame! Use the frame throughout the month of March to show your support for Myeloma Action Month. Thank you for spreading the message of hope!

Register Now Button.png

LearnMoreButton.png

| INSPIRATION | Fresh Swag

MAM Banner.png

Shop Now for Signature Myeloma Warrior Merchandise

The #myelomawarrior program celebrates all those with the Warrior Spirit. According to IMF Chairman of the Board Dr. Brian G.M. Durie, the #myelomawarrior spirit means having “energy and resilience” to live well with and care for those with multiple myeloma, all while marching toward a cure. The #myelomawarrior merchandise is made from a high-quality cotton blend, with comfort in mind for both men and women. Shop now for sweatshirts, T-shirts, hats, and wristbands.

ShopNowButton.png

| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series

SevagDurieVideoBox2.jpg

CLINICAL TRIALS
EVENTS

New isatuximab Clinical Trial: the IMROZ Study

New isatuximab Clinical Trial: the IKEMA Study

Join the conversation about myeloma on the Smart Patients Message Board

March 15-16, 2019
IMF Patient & Family Seminar
Boca Raton, FL

March 23, 2019
Regional Community Workshop
La Jolla, CA

April 5-6, 2019
IMF Patient & Family Seminar
Short Hills, NJ

April 6, 2019
Regional Community Workshop
Seattle, WA

April 27, 2019
2019 Miles for Myeloma 5K Run/Walk
Philadelphia, PA

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, Sanofi-Genzyme, and Takeda Oncology
and individuals like you who supported the IMF this year

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.